Neximmune Inc expected to post a loss of 53 cents a share - Earnings Preview

Neximmune

03/03/2023 11:28

* Neximmune Inc  NEXI.OQ   NEXI.O  is expected to show no
change
in quarterly revenue when it reports  results on March 7
(estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for Neximmune Inc is
for a
loss of 53 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Neximmune
Inc is
$2​, above​ its last closing price of $0.49. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2022  -0.72       -0.69      -0.60     Beat    13.7
 Jun. 30 2022  -0.69       -0.68      -0.69     Missed  -1.5
 Mar. 31 2022  -0.70       -0.70      -0.66     Beat    6.2​
 Dec. 31 2021  -0.75       -0.78      -0.69     Beat    11.5
 ​​Sep.        -0.63       -0.64      -0.65     Missed  -1
 30 2021                                                
 Jun. 30 2021  -0.51       -0.51      -0.54     Missed  -5.9​
 Mar. 31 2021  -0.67       -0.66      -0.71     Missed  -7
 This summary was machine generated March 3 at 11:28 GMT.  All
figures in US dollars  unless otherwise stated